N Engl J Med. 2017 Mar 23;376(12):1158. doi: 10.1056/NEJMicm1609306.
PMID:28328332
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects.
Tentolouris A, Vlachakis P, Tzeravini E, Eleftheriadou I, Tentolouris N.
Int J Environ Res Public Health. 2019 Aug 17;16(16):2965. doi: 10.3390/ijerph16162965.
PMID:31426529
Fournier Gangrene in a Patient With Type 2 Diabetes Mellitus Treated With Dapagliflozin: A Case Report.
Moon JY, Lee MR, Kim JH, Ha GW.
Ann Coloproctol. 2021 Jul;37(Suppl 1):S48-S50. doi: 10.3393/ac.2020.06.22. Epub 2021 May 28.
PMID:34044501
Fournier's Gangrene in a Patient with Type 2 Diabetes Mellitus Treated with Empagliflozin: A Case Report.
Nagano Y, Yakame NK, Aoki H, Yamakawa T, Kondo NI.
Drug Saf Case Rep. 2019 Oct 18;6(1):11. doi: 10.1007/s40800-019-0105-8.
PMID:31628552
Fournier's Gangrene under Sodium-Glucose Cotransporter-2 Inhibitors Therapy in Gynecological Patients.
Serrano Olave A, Bueno Moral AI, Martínez Bañón C, González Mesa E, Jiménez López JS.
Int J Environ Res Public Health. 2022 May 21;19(10):6261. doi: 10.3390/ijerph19106261.
PMID:35627798
Fournier's gangrene.
Wang YK, Li YH, Wu ST, Meng E.
QJM. 2017 Oct 1;110(10):671-672. doi: 10.1093/qjmed/hcx124.
PMID:28655178
Fournier's gangrene as a rare complication in patient with uncontrolled type 2 diabetes treated with surgical debridement: A case report and literature review.
Provenzano D, Lo Bianco S, Zanghì M, Campione A, Vecchio R, Zanghì G.
Int J Surg Case Rep. 2021 Feb;79:462-465. doi: 10.1016/j.ijscr.2021.01.098. Epub 2021 Jan 30.
PMID:33757263
Fournier's gangrene in a patient on dapagliflozin treatment for type 2 diabetes.
Onder CE, Gursoy K, Kuskonmaz SM, Kocer U, Culha C.
J Diabetes. 2019 May;11(5):348-350. doi: 10.1111/1753-0407.12896. Epub 2019 Feb 5.
PMID:30604507
Fournier's Gangrene with Growth of Actinomyces europaeus: A Case Report.